All Shareholder Proposals

Click on the magnifying glass to view more info.

Filter results:

Showing 101–150 of 390 filings

Meeting Date Company Form ▲ Short Summary ESG View
2026-04-28 Constellation Energy Corp DEF 14A Assess and report whether Constellation’s DEI initiatives are supported by net-present-value and return-on-investment analyses, including opportunity costs and litigation/reputational risks. S G
2026-05-01 CHURCH & DWIGHT CO INC /DE/ DEF 14A Authorize shareholders to take corporate action by written consent if they hold at least the number of votes required to approve the action at a meeting. G
2026-05-04 AFLAC INC DEF 14A Adopt a policy requiring the Chairman and CEO roles to be separate and that the Board Chair be an independent director. S G
2026-05-05 DOMINION ENERGY, INC DEF 14A Require the Board to adopt a policy separating the Chair and CEO roles and to prefer an independent director as Chair. G
2026-05-05 DOMINION ENERGY, INC DEF 14A Commission and publish a report evaluating risks to shareholder value, reputation, and legal compliance from using ESG and DEI metrics in executive compensation. S G
2026-05-05 DOMINION ENERGY, INC DEF 14A Prepare a report identifying options to establish dedicated shareholder engagement channels such as an advisory panel or online portal. S G
2026-04-29 BORGWARNER INC DEF 14A Allow stockholders holding the minimum number of votes necessary to authorize an action at a meeting to take action by written consent without ownership-length restrictions. G
2026-04-29 HUNTINGTON INGALLS INDUSTRIES, INC. DEF 14A Disclose an annual report on the Company’s political spending, including policies, procedures, and detailed direct and indirect contributions and recipients. G
2026-04-28 BRINKS CO DEF 14A Publish a report disclosing employee retention rates by demographic categories (e.g., veteran status, age, gender, race, disability), prepared at reasonable cost and omitting proprietary information. S G
2026-04-29 AES CORP DEF 14A Allow shareholders owning 10% of outstanding common stock to call a special shareholder meeting. G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Adopt an enduring policy requiring the roles of Board Chair and CEO be held by separate persons and that the Chair be an independent director. G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Commission a report assessing how extending patent exclusivities could delay biosimilars and novel therapeutics and thereby hinder patient access. S G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Commission and publish a report evaluating risks to shareholder value, reputation and legal compliance from incorporating ESG and DEI metrics into executive compensation. S G
2026-04-30 CROWN HOLDINGS, INC. DEF 14A Amend governing documents to permit shareholders holding the minimum number of votes required to act by written consent to initiate and approve actions without requiring a meeting. G
2026-04-29 GOLDMAN SACHS GROUP INC DEF 14A Lower the shareholder threshold to call a special meeting from 25% to 10%. G
2026-05-06 ENTEGRIS INC DEF 14A Give shareholders owning a combined 10% of outstanding common stock the right to call a special shareholder meeting (including online meetings) without a minimum holding period. G
2026-04-29 GOLDMAN SACHS GROUP INC DEF 14A Disclose an annual report identifying charitable recipients over $5,000, donation purposes, future plans, reputational risk and risk analysis. S
2026-04-29 GOLDMAN SACHS GROUP INC DEF 14A Publish an annual Energy Supply Ratio (ESR) disclosing financing for low‑carbon versus fossil‑fuel energy and the methodology used. E
2026-05-06 REGIONS FINANCIAL CORP DEF 14A Grant shareholders holding 10% of outstanding common stock the ability to call a special shareholder meeting. G
2026-05-08 AbbVie Inc. DEF 14A Adopt a policy to require the board chair be an independent director and amend the bylaws as necessary. G
2026-05-13 INTEL CORP DEF 14A Disclose and assess Intel’s China business dealings and quantify material revenue and asset exposure, as well as related mitigation steps, and publish a report within one year. S G
2026-05-13 INTEL CORP DEF 14A Commission and publish an independent review assessing the effectiveness of Intel’s human rights due diligence in conflict-affected and high-risk areas and disclose findings, gaps, and remedial actions. S G
2026-05-13 INTEL CORP DEF 14A Adopt a policy requiring separation of the Board Chair and CEO roles with an independent Chair (not replaceable by a lead director) and implement as soon as practicable. G
2026-05-14 KIMBERLY CLARK CORP DEF 14A Require Kimberly-Clark to adopt a policy and amend its bylaws to ensure the Board Chair is an independent director. G
2026-05-04 BANK OF AMERICA CORP /DE/ DEF 14A Require the Board to separate the Chair and CEO roles and adopt a policy favoring an independent Chair. G
2026-05-04 BANK OF AMERICA CORP /DE/ DEF 14A Publish a report disclosing whether and how the Board oversees material risks related to animal welfare in the company’s financing decisions. E S G
2026-05-14 AT&T INC. DEF 14A Permit shareholders to act by written consent with the minimum number of votes required to approve an action at a fully attended meeting, without ownership-length or holding-method restrictions. G
2026-05-14 AT&T INC. DEF 14A Adopt a policy to disclose AT&T’s Consolidated EEO‑1 workforce report annually on the company website and in the proxy statement. S G
2026-05-04 FIRST CITIZENS BANCSHARES INC /DE/ DEF 14A Conduct an evaluation and publish a report on the reputational, human capital, operational, legal, and other risks of failing to allow faith-based employee resource groups. S
2026-05-05 TYLER TECHNOLOGIES INC DEF 14A Disclose annually Tyler’s policies and procedures and all monetary and non-monetary contributions (direct and indirect) used to intervene in political campaigns or influence elections, including recipients and amounts. G
2026-05-04 ASBURY AUTOMOTIVE GROUP INC DEF 14A Lower the required shareholder threshold to call a special meeting to holders of 10% of outstanding common stock. G
2026-05-12 TransUnion DEF 14A Amend governing documents to allow shareholders holding 10% of outstanding common stock to call a special shareholder meeting. G
2026-05-08 DOVER Corp DEF 14A Adopt a policy requiring the roles of Board Chair and CEO be held by separate individuals and that the Board Chair be an independent director. G
2026-05-07 EASTMAN CHEMICAL CO DEF 14A Lower the threshold for calling a special shareholder meeting to 10% of outstanding common stock. G
2026-05-05 ALBEMARLE CORP DEF 14A Allow shareholders owning a combined 10% of outstanding common stock to call a special shareholder meeting (including online meetings). G
2026-05-08 UNITED RENTALS, INC. DEF 14A Require directors who fail to receive a majority vote in an uncontested election to resign and vacate their board seat within nine months. G
2026-05-07 WOLVERINE WORLD WIDE INC /DE/ DEF 14A Report new policies or practices to increase Wolverine Worldwide’s climate ambitions and emission-reduction goals, including potential GHG reduction targets and a transition plan. E S G
2026-04-21 BIO-RAD LABORATORIES, INC. DEF 14A Adopt a one-vote-per-share policy and phase out Bio‑Rad’s dual-class capital structure. G
2026-05-05 BRISTOL MYERS SQUIBB CO DEF 14A Adopt an enduring policy requiring the Board Chair to be an independent director and separate the Chair and CEO roles. G
2026-05-07 BLACKLINE, INC. DEF 14A Declassify the Board so that all directors are elected annually beginning at the next Annual Meeting. G
2026-05-05 CARVANA CO. DEF 14A Adopt an enduring policy to separate the roles of Board Chair and CEO and require the Board Chair to be an independent director. G
2026-05-14 WYNDHAM HOTELS & RESORTS, INC. DEF 14A Permit stockholders to act by written consent to approve corporate actions without holding a meeting. G
2026-05-08 COLGATE PALMOLIVE CO DEF 14A Remove DEI from Board candidate considerations. S G
2026-05-08 COLGATE PALMOLIVE CO DEF 14A Adopt policy to separate the roles of Board Chairman and CEO and require an independent Board Chairman. G
2026-05-05 AMERICAN EXPRESS CO DEF 14A Conduct an independent evaluation and publish a report analyzing legal, regulatory, political, reputational and other risks of providing transgender medical treatments to minors under the company’s healthcare plans. S G
2026-05-05 AMERICAN EXPRESS CO DEF 14A Amend the bylaws to create a standing Political Bias Committee to oversee risks from board and management political bias and produce an annual report on its oversight activities. S G
2026-05-05 SKYWEST INC DEF 14A Commission an independent third-party assessment of SkyWest’s alignment with ILO freedom-of-association and collective-bargaining standards. S G
2026-05-08 CAPITAL ONE FINANCIAL CORP DEF 14A Require shareholder approval for any Named Executive Officer severance/termination payment exceeding 2.99 times base salary plus target bonus. G
2026-05-12 CENTENE CORP DEF 14A Adopt a policy to separate the roles of Board Chair and CEO and require the Board Chair to be an independent director. G
2026-05-12 PRUDENTIAL FINANCIAL INC DEF 14A Require the Board to separate the roles of Chairman and CEO and have an independent director serve as Board Chairman. G